Cite
Taura N, Ichikawa T, Miyaaki H, et al. Baseline serum cholesterol is associated with a response to pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C genotype 2. Gastroenterol Res Pract. 2012;2012:317580doi: 10.1155/2012/317580.
Taura, N., Ichikawa, T., Miyaaki, H., Kadokawa, Y., Tsutsumi, T., Tsuruta, S., Kato, Y., Inoue, O., Kinoshita, N., Ohba, K., Kato, H., Ohata, K., Masuda, J., Hamasaki, K., Yatsuhashi, H., & Nakao, K. (2012). Baseline serum cholesterol is associated with a response to pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C genotype 2. Gastroenterology research and practice, 2012317580. https://doi.org/10.1155/2012/317580
Taura, Naota, et al. "Baseline serum cholesterol is associated with a response to pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C genotype 2." Gastroenterology research and practice vol. 2012 (2012): 317580. doi: https://doi.org/10.1155/2012/317580
Taura N, Ichikawa T, Miyaaki H, Kadokawa Y, Tsutsumi T, Tsuruta S, Kato Y, Inoue O, Kinoshita N, Ohba K, Kato H, Ohata K, Masuda J, Hamasaki K, Yatsuhashi H, Nakao K. Baseline serum cholesterol is associated with a response to pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C genotype 2. Gastroenterol Res Pract. 2012;2012:317580. doi: 10.1155/2012/317580. Epub 2012 Nov 05. PMID: 23193392; PMCID: PMC3501951.
Copy
Download .nbib